MicroRNA and Cancer Immunology

Dear Colleagues,

I am pleased to invite you to contribute to this Special Issue on “MicroRNA and Cancer Immunology” in Cancers. This issue seeks to illuminate the critical role of microRNAs (miRNAs) in the complex interplay within the tumor microenvironment and their impact on cancer progression. Recent research underscores the significance of miRNAs as modulators of immune cell function, tumor angiogenesis, and epithelial–mesenchymal transition (EMT). Their potential as biomarkers and therapeutic targets in cancer diagnosis, prognosis, and treatment highlights the importance of this burgeoning field.

This Special Issue aims to collate and disseminate cutting-edge research and reviews exploring the multifaceted roles of miRNAs in cancer immunology. Our goal is to provide a comprehensive overview of current advances and encourage discussions that may shape future research directions in this vital area.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:

• miRNA roles in tumor microenvironment modulation and tumor evasion.
• New miRNA targets that affect both cancer progression and EMT.
• The impact of miRNA on tumor angiogenesis and metastasis.
• miRNA as biomarkers for cancer diagnosis and prognosis.
• Therapeutic potential of miRNA in cancer treatment.
• Novel methodologies in miRNA research related to cancer immunology.
• miRNA which involves immunometabolism in cancer.

We look forward to receiving your contributions and fostering a rich dialogue in this dynamic and vital field of cancer research.

Dr. Behzad Mansoori
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• microRNA
• miRNA
• tumor microenvironment
• biomarkers
• cancer immunology
• cancer treatment
• therapeutic target
• tumor angiogenesis
• tumor metastasis